Atherosclerosis
Volume 197, Issue 2 , Pages 579-587 , April 2008

A novel method for production of lipid hydroperoxide- or oxysterol-rich low-density lipoprotein

Received 28 March 2007 ,Revised 16 August 2007 ,Accepted 20 August 2007.

References 

  1. Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?. Circulation. 2002;105:2107–2111
  2. Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G, Jűrgens G. Biochemical, structural, and functional properties of oxidised low-density-lipoprotein. Chem Res Toxicol. 1990;3:77–92
  3. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low-density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low-density lipoprotein phospholipids. Proc Natl Acad Sci USA. 1984;81:3833–3887
  4. Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low-density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest. 1984;74:1890–1894
  5. Leake DS, Rankin SM. The oxidative modification of low-density lipoprotien by macrophages. Biochem J. 1990;270:741–748
  6. Ferns GA, Lamb DJ, Taylor A. The possible role of copper ions in atherogenesis: the Blue Janus. Atherosclerosis. 1997;133:139–152
  7. Lougheed M, Steinbrecher UP. Mechanism of uptake of copper-oxidised low-density lipoprotein in macrophages is dependent on its extent of oxidation. J Biol Chem. 1996;271:11798–11805
  8. Fong LG, Parthasarathay S, Witztum JL, Steinberg D. Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100. J Lipid Res. 1987;28:1466–1477
  9. Carpenter KL, Wilkins GM, Fussell B, et al. Production of oxidised lipids during modification of low-density lipoprotein by macrophages or copper. Biochem J. 1994;304:625–633
  10. Gieseg SP, Pearson J, Firth CA. Protein hydroperoxides are a major product of low-density lipoprotein oxidation during copper, peroxyl radical and macrophage-mediated oxidation. Free Radic Res. 2003;37:983–991
  11. Berliner JA, Territo MC, Sevanian A, et al. Minimally modified low-density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990;85:1260–1266
  12. Hazell LJ, Davies MJ, Stocker R. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins. Biochem J. 1999;339:489–495
  13. Roland A, Patterson RA, Leake DS. Measurement of copper-binding sites on low-density lipoprotein. Arterioscler Thromb Vasc Biol. 2001;21:594–602
  14. Harris LK, Mann GE, Ruiz E, Mushtaq S, Leake DS. Ascorbate does not protect against apoptosis induced by oxidised low-density lipoprotein. Arch Biochem Biophys. 2006;455:68–76
  15. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Free Radic Res Commun. 1989;6:67–75
  16. Wilkins GM, Leake DS. The effect of inhibitors of free radical generating enzymes on low-density lipoprotein oxidation by macrophages. Biochim Biophys Acta. 1994;1211:69–78
  17. Schacterle GR, Pollack RL. A simplified method for the quantitative assay of small amounts of protein in biologic material. Anal Biochem. 1973;51:654–655
  18. El-Saadani M, Esterbauer H, el-Sayed M, et al. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res. 1989;30:627–630
  19. Khoo JC, Miller E, McLoughlin P, Steinberg D. Enhanced macrophage uptake of low-density lipoprotein after self-aggregation. Arteriosclerosis. 1988;8:348–358
  20. Kritharides L, Jessup W, Gifford J, Dean RT. A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC. Anal Biochem. 1993;213:79–89
  21. Stait SE, Leake DS. Ascorbic acid can either increase or decrease low-density lipoprotein modification. FEBS Lett. 1994;341:263–267
  22. Brown AJ, Dean RT, Jessup W. Free and esterified oxysterol: formation during copper-oxidation of low-density lipoprotein and uptake by macrophages. J Lipid Res. 1996;37:320–335
  23. Jones CM, Burkitt MJ. EPR spin-trapping evidence for the direct, one-electron reduction of tert-butylhydroperoxide to the tert-butoxyl radical by copper(II): paradigm for a previously overlooked reaction in the initiation of lipid peroxidation. J Am Chem Soc. 2003;125:6946–6954
  24. Wilcox AL, Marnett LJ. Polyunsaturated fatty acid alkoxyl radicals exist as carbon-centered epoxyallylic radicals—a key step in hydroperoxide-amplified lipid peroxidation. Chem Res Toxicol. 1993;6:413–416
  25. Sparrow CP, Parthasarathy S, Steinberg D. A macrophage receptor that recognizes oxidised low-density lipoprotein but not acetylated low-density lipoprotein. J Biol Chem. 1989;264:2599–2604
  26. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res. 1998;39:1529–1542
  27. Suarna C, Dean RT, May J, Stocker R. Human atherosclerotic plaque contains both oxidised lipids and relatively large amounts of a tocopherol and ascorbate. Atheroscler Thromb Vasc Biol. 1995;15:1616–1624
  28. Kritharides L, Upston J, Jessup W, Dean RT. Accumulation and metabolism of low-density lipoprotein-derived cholesteryl linoleate hydroperoxide and hydroxide by macrophages. J Lipid Res. 1998;39:2394–2405

PII: S0021-9150(07)00533-3

doi: 10.1016/j.atherosclerosis.2007.08.026

Atherosclerosis
Volume 197, Issue 2 , Pages 579-587 , April 2008

Article Tools

* Image Usage & Resolution